OREANDA-NEWS. February 12, 2013. McKesson Corporation (NYSE: MCK) reported that revenues for the third quarter ended December 31, 2012 were USD 31.2 billion, up 1% compared to USD 30.8 billion a year ago.  On the basis of U.S. generally accepted accounting principles (“GAAP”), third-quarter earnings per diluted share was USD 1.24 compared to USD 1.20 a year ago, reported the press-centre of McKesson.   

Third-quarter Adjusted Earnings per diluted share was USD 1.41, up 1% compared to \\$1.40 a year ago. 

For the first nine months of the fiscal year, McKesson generated cash from operations of USD 276 million, and ended the quarter with cash and cash equivalents of USD 2.7 billion.  During the first nine months of the fiscal year, the company paid USD 147 million in dividends, had internal capital spending of USD 268 million and spent USD 577 million on acquisitions.   The company also repurchased USD 360 million of its common stock during the third quarter. 

Distribution Solutions revenues were up 1% in the third quarter, driven mainly by growth in our U.S. pharmaceutical direct distribution and services business and growth in our Medical-Surgical distribution business.   

Canadian revenues, on a constant currency basis, increased 3% for the third quarter.  Including the favorable currency impact of 3%, Canadian revenues increased 6% for the third quarter. 

Medical-Surgical distribution and services revenues were up 15% for the third quarter, driven by market growth, new customers, acquisitions and one additional sales day.

In the third quarter, Distribution Solutions GAAP operating profit was \\$525 million and GAAP operating margin was 1.73%.  Third-quarter adjusted operating profit was USD 569 million and the adjusted operating margin was 1.87%.  Distribution Solutions third-quarter segment results include a USD 40 million pre-tax charge related to a legal dispute in our Canadian business.

Technology Solutions revenues were flat in the third quarter compared to the prior year.  GAAP operating profit was USD 79 million for the third quarter and GAAP operating margin was 9.56%.  Adjusted operating profit was USD 98 million for the third quarter and adjusted operating margin was 11.86%.  Technology Solutions third-quarter segment results were impacted by revenue deferral in our international business.

“Our full year view of the operating performance in our Distribution Solutions segment is now better than our original expectations, and our full year view of the operating performance in the primary businesses in Technology Solution remains unchanged,” said John H. Hammergren, chairman and chief executive officer.   “This operating strength is offset by the charge in our Canadian business and revenue deferral in our international technology business, and as a result we are updating our previous outlook for the fiscal year and now expect Adjusted Earnings per diluted share of USD 7.10 to USD 7.30 for the fiscal year ending March 31, 2013.”

Fiscal Year 2013 Outlook

McKesson expects Adjusted Earnings per diluted share of USD 7.10 to USD 7.30 for the fiscal year ending March 31, 2013, which excludes the following GAAP items:

Amortization of acquisition-related intangible assets of approximately 55 cents per diluted share in Fiscal 2013.

Acquisition expenses and related adjustments expected to add approximately 13 cents per diluted share, including the impact of the \\$81 million pre-tax gain on business combination related to the acquisition of the remaining 50% ownership in McKesson’s corporate headquarters building completed during the first quarter.

Litigation reserve adjustments of approximately 15 cents per diluted share.

Adjusted Earnings
McKesson separately reports financial results on the basis of Adjusted Earnings.  Adjusted Earnings is a non-GAAP financial measure defined as GAAP income from continuing operations, excluding amortization of acquisition-related intangible assets, acquisition expenses and related adjustments, and certain litigation reserve adjustments.  A reconciliation of McKesson’s financial results determined in accordance with GAAP to Adjusted Earnings is provided in Schedules 2, 3 and 4 of the financial statement tables included with this release.